HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sudden deafness as the initial manifestation of chronic myelogenous leukemia: case report].

Abstract
To study the pathogenesis of hearing loss in chronic myelogenous leukemia (CML). To report one case with CML whose first sign was sudden unilateral hearing loss. Sudden hearing loss in CML was presented with dramatic high white blood cell count in peripheral blood. Some cases of sudden hearing loss in CML may be improved or even cured by leukapheresis and intrathecal chemotherapy. The proposed pathogenesis for deafness in leukemia is due to hyperleukocytosis, hyperviscosity syndrome, leukemic infiltration and the inner ear hemorrhage. In treatment, clinicians should quickly reduce the number of white blood cells to lighten the tumor burden. Intrathecal injection of MTX and plasmapheresis is commonly used.
AuthorsYandi Chen, Lifeng An, Guanghua Jin
JournalLin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery (Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi) Vol. 29 Issue 10 Pg. 952-3 (May 2015) ISSN: 2096-7993 [Print] China
PMID26596019 (Publication Type: Case Reports, Journal Article)
Topics
  • Ear, Inner (pathology)
  • Hearing Loss, Sudden (etiology)
  • Hearing Loss, Unilateral (etiology)
  • Hemorrhage (pathology)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (complications)
  • Leukocyte Count

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: